Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer. - Wikidata - wikimedia - TriplyDB

Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.

Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.

http://www.wikidata.org/entity/Q33423808

about

Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer Targeting translation initiation in breast cancer Modeling vitamin D actions in triple negative/basal-like breast cancer.Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.Detection of gene pathways with predictive power for breast cancer prognosis.Quantitative proteomic analysis of single pancreatic islets.In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology Challenges to developing proteomic-based breast cancer diagnostics.Laser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue --- optimization for genome wide array analyses Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.Is the time ripe for kidney tissue proteomics?Bacterial proteins and peptides in cancer therapy: today and tomorrow Plasma membrane proteomics and its application in clinical cancer biomarker discovery.Making sense out of massive data by going beyond differential expression Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue.Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs.The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.Genome Medicine: past, present and future.Prediction of individual response to anticancer therapy: historical and future perspectives A serum protein profile predictive of the resistance to neoadjuvant chemotherapy in advanced breast cancers.INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cells INT6/EIF3E Controls the RNF8-Dependent Ubiquitylation Pathway and Facilitates DNA Double-Strand Break Repair in Human Cells.Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer.The Drosophila orthologue of the INT6 onco-protein regulates mitotic microtubule growth and kinetochore structure.The chromosome 3q26 OncCassette: A multigenic driver of human cancer.Antiestrogen Resistance and the Application of Systems Biology Nuclear distribution of eIF3g and its interacting nuclear proteins in breast cancer cells.Beyond laser microdissection technology: follow the yellow brick road for cancer research.Association of Over-Expressed Estrogen Receptor Alpha with Development of Tamoxifen Resistant Hyperplasia and Adenocarcinomas in Genetically Engineered Mice Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.Proteomic analysis of tissue samples in translational breast cancer research.Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells.Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells.Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium.TGF-β1-Induced Epithelial-Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells.

P2860

Q24626049-7B9A9F3A-E2A9-4F0F-B031-DD81A6E08C0B Q24632628-33AF8369-6F27-4C49-9812-5CD00EE45431 Q27027284-F6EC3269-456B-49E7-A399-32EA7F28E6CC Q27693209-6DB06F42-1B0B-40CD-BC47-9426338EAA05 Q30401624-1F73576C-2D04-4202-8EEC-028201F63831 Q30493620-51CE0A1C-E9D3-4ED4-AA90-8E5EBCE32BEC Q33511709-5745FBD9-11BF-44EA-85B2-12D58488BE01 Q33672680-C4B9A33C-C3D2-48CD-AF14-F5756230D956 Q33823926-87B0D913-CA2B-417F-8C87-D3D4EC789B89 Q33850268-6DC1A6B0-5A1E-4D37-AC52-FDA94A1264D9 Q33850657-B86D21C2-2C5D-45D0-A6A9-8D1E4422D2B3 Q33888480-329241E5-8984-4A11-B292-B523AFB3A65F Q34075830-BEDE1F3F-5BAE-4238-97EF-18226296172B Q34122107-B7EBFDDB-6A11-4240-96EF-D094841EF51E Q34207981-0989AA33-9BA1-4B51-9AD9-0F8540B9EB0E Q34285532-69681570-F4C3-4512-9797-9C3C08034873 Q34514089-AA396D14-1384-4C29-B6BD-DF449F2CFCF3 Q34644859-1E13223A-25ED-414D-BE18-5F4F53C2EE0D Q34857146-3C72C171-9B33-4766-B6AC-9EF558AA6DA3 Q34918110-006CEEA8-2EF4-43BD-A4AC-00CA6BAF9E8A Q34971361-EA4881D1-0BE1-493A-B805-95E32F8E7D2A Q35024682-B237B5EE-EAB9-45D4-A327-6DD486B45653 Q35497722-4CDEE458-8228-4FDE-98E2-947F7E56F328 Q35909521-050224FA-279D-4337-8EDF-9DD505F0995A Q36109836-83BE58C1-B7DD-40FF-A2D3-BCF6EC4493B4 Q36241768-F110E57E-BFD3-4912-B390-ED144F587D41 Q36263003-C9BC7685-01EA-481E-84ED-DFBBC4667F85 Q36372104-CED0888E-2177-4BF9-B352-5937AC1B8AD3 Q36510237-266F69E3-C40C-44D0-9965-6A04B7024EB9 Q36713946-C6C6FA94-F567-436E-8D84-6017DD48247B Q36722093-CA385A6C-4B22-4FA5-A5D4-895A9D053A4C Q37516295-3FA3A259-234A-45DD-A6C3-7AB61880794E Q37599164-04C2C5F4-38C0-4DD2-9B29-9FDAAEA460E7 Q37634494-B439D62F-115C-4442-977C-09A844610634 Q37651691-833CA396-E2BC-4437-B834-D87F0A9E0A51 Q38212502-BD72EE4C-DAEF-4AC7-B584-F7034A7AF4EF Q38344755-D4CB0B3F-DF33-456A-9A6F-AD9F2759C0C9 Q39439111-1B6E3562-7075-4A8F-9995-9099CCB071BF Q39648518-5B81CC5A-3E77-4B10-B0A7-383544DB1857 Q41828176-43BB4EAD-08CB-4A62-912B-89A7BA9AB23A

P2860

Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.

http://www.wikidata.org/entity/Q33423808

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Identification of a putative p ...... y resistance in breast cancer.

@ast

Identification of a putative p ...... y resistance in breast cancer.

@en

type

label

Identification of a putative p ...... y resistance in breast cancer.

@ast

Identification of a putative p ...... y resistance in breast cancer.

@en

prefLabel

Identification of a putative p ...... y resistance in breast cancer.

@ast

Identification of a putative p ...... y resistance in breast cancer.

@en

P1433

Q33423808-D809FF1B-FBB2-4483-8FFE-921971067D88

P1476

Q33423808-039F2413-83B5-4330-B769-D91A969AFE17

P2093

Q33423808-0C650604-6D04-47A4-AD7C-31B9B7466818

Q33423808-0CC8BE75-68E3-4587-9AD9-DE6BADF10F5B

Q33423808-3758E9AB-DA56-412D-BFA0-B7DF98868D79

Q33423808-3E8398E0-D725-49E9-BE65-D1CC1436121E

Q33423808-53E329DD-02F0-4532-9DF1-B8DFC5F10E5A

Q33423808-72840217-C106-483C-B916-D7629AF292B5

Q33423808-8808B5BF-CCDA-4E90-9886-7F53E872CB22

Q33423808-B8342AAA-BB52-4B46-972F-62E0164862D6

Q33423808-C5FF1FF5-6241-4DBC-833F-16DFD1129596

Q33423808-E12DC556-E71B-4A01-8420-052CE7F3A319

P2860

Q33423808-000D1F5E-EB27-409B-86F0-E04B8502B51C

Q33423808-05CF70A6-8E52-4FB7-8752-0A5CE383787B

Q33423808-08744ECC-0E9B-40BC-8608-EF2425B380DD

Q33423808-0C8DC1CF-91AC-491E-8E2E-1C7C29CEBA42

Q33423808-0EEB5B5B-1091-4C53-956D-23520E35A2E1

Q33423808-12FFE1BA-472F-4DA3-81C7-FF653FC500E0

Q33423808-1AAA393A-37F0-40A7-AF57-7A2D151CE248

Q33423808-1AC3A32E-A7D1-4E87-AB30-6B2EF92D7F2E

Q33423808-1AE5F9EF-0C9F-4DA9-8267-6B866C0D2A8B

Q33423808-1CAF8617-FC53-49C1-8875-6DF57D6E1E03

P304

Q33423808-751366FA-90BF-438C-9497-6F3538A56760

P31

Q33423808-179872A6-8D93-40C9-9511-93A08EC2D474

P356

Q33423808-A979840F-B361-4CB8-A24E-F318D84D403F

P433

Q33423808-9AAA0E37-9DC4-47C8-B036-8F7E87F7C3F0

P478

Q33423808-1621D14A-5174-4CF9-B8F0-F9DF33AEB407

P50

Q33423808-F62AB82D-7175-4231-8AAB-AB8FD3304A79

P577

Q33423808-58879A49-780B-4332-B589-5D7E7664DE61

P698

Q33423808-2B5AEC6F-B487-4B63-9852-3297F7C6581A

P932

Q33423808-A416C1A0-5FF0-472A-B082-1CCADA79DDFE

P356

MCP.M800493-MCP200

P1433

Molecular & Cellular Proteomics

P1476

Identification of a putative p ...... y resistance in breast cancer.

@en

P2093

Annemieke M Timmermans

http://www.w3.org/2001/XMLSchema#string

Arzu Umar

http://www.w3.org/2001/XMLSchema#string

John A Foekens

http://www.w3.org/2001/XMLSchema#string

John W M Martens

http://www.w3.org/2001/XMLSchema#string

Ljiljana Pasa-Tolić

http://www.w3.org/2001/XMLSchema#string

Marion E Meijer-van Gelder

http://www.w3.org/2001/XMLSchema#string

Maxime P Look

http://www.w3.org/2001/XMLSchema#string

Michael A den Bakker

http://www.w3.org/2001/XMLSchema#string

Navdeep Jaitly

http://www.w3.org/2001/XMLSchema#string

Theo M Luider

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation

Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Clinical importance of the cytochromes P450

Laser capture microdissection

VIPER: an advanced software package to support high-throughput LC-MS peptide identification

ENPP1 gene, insulin resistance and related clinical outcomes

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

P304

1278-1294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M800493-MCP200

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19329653

http://www.w3.org/2001/XMLSchema#string

P932

2690491

http://www.w3.org/2001/XMLSchema#string